All Karen Akinsanya (president of R&D therapeutics and chief strategy officer of partnerships at Schrödinger) articles
-
NewsSchrödinger partners with Lilly TuneLab on AI drug discovery
Schrödinger has announced a collaboration with Eli Lilly’s TuneLab platform, integrating advanced AI-driven drug discovery workflows into its LiveDesign enterprise informatics system.